The compound has been investigated from the patent literature for its anxiolytic Houses and decreased sedative, hypnotic, and ataxic facet-effects, but it does not appear to be accredited for clinical use. Łukasik-Głebocka et al Pyrazolam can be a triazolo-BZD with apparently hardly any data, structurally similar to alprazolam but https://buyflubromazolampowder97859.humor-blog.com/35011897/the-5-second-trick-for-flubromazolam-drug